Ep 80 - De-risking Your Science: What Makes Biotech Investable, With Daisy Robinton

In this episode of Invisible Ink, molecular biologist and biotech entrepreneur Daisy Robinton, founder of Oviva Therapeutics, joins Shubha Chakravarthy to share her journey from academia to leading a women’s health startup.

Daisy turned a personal encounter with gaps in female physiology knowledge—despite holding a PhD— into her mission to address ovarian function as a key driver of women’s healthspan, all the way to a successful exit in a tough funding and M&A environment.

Check out this episode for her thoughtful and pragmatic insights on:

1. How to transition successfully from a scientist to founder
2. How to tell if your biotech asset is ready for commercialization
3. How to balance science and business as a scientist-founder
4. The challenges of fundraising in biotech and how to set yourself up for success
5. The art of making science-business tradeoffs, and how to do it well
6. How to convince skeptical male investors of the market opportunity in women's health
7. Tested tips from the trenches for first time CEO's
8. Why storytelling is a game changer, and how to do it well for any audience
9. Thinking ahead: exit and post-exit realities
10. Tips to leverage your scientific training to translate into any domain

and much more!